Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report 2026

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Overview

• Polymerase Chain Reactions (PCR) Devices, Reagents And Uses market size has reached to $6.51 billion in 2025 • Expected to grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Prevalence Of Infectious Diseases Fuels Growth In PCR Devices And Reagents Market • Market Trend: Revolutionizing Allergen Detection with Advanced Diagnostic Tools • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

Polymerase Chain Reaction (PCR) devices and reagents are designed to aid scientists in producing multiple copies of specific DNA segments. In PCR, a section of the genome to be amplified is chosen using short synthetic DNA fragments called primers, and the segment is subsequently amplified through numerous rounds of DNA synthesis. The main products of Polymerase Chain Reactions (PCR) devices and reagents are instruments, reagents, and consumables. An instrument is a tool or device for doing a particular kind of work. The instruments used are standard PCR, rt- PCR, and digital PCR. The various end-users are the pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academics, and research organizations.

What Is The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Growth Forecast?

The polymerase chain reactions (pcr) devices, reagents and uses market size is expected to see strong growth in the next few years. It will grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growth in personalized medicine, rising cancer diagnostics, expansion of genetic screening, increasing research funding, demand for rapid diagnostics. Major trends in the forecast period include rising demand for molecular diagnostics, expansion of infectious disease testing, increased adoption of real-time PCR, growth of research-based pcr applications, miniaturization of pcr instruments.

Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Segmentation

1) By Product: Instruments, Reagents, Consumables 2) By Instruments: Standard PCR, RT-PCR, Digital PCR 3) By End User: Pharmaceutical And Biotechnology Industries, Clinical Diagnostics Labs And Hospitals, Academics And Research Organization Subsegments: 1) By Instruments: Thermal Cyclers, Real-Time PCR Systems, Digital PCR Systems 2) By Reagents: Master Mixes, Primers And Probes, Enzymes, Nucleotides 3) By Consumables: PCR Tubes, PCR Plates, Seals And Films, Pipette Tips

What Is The Driver Of The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

The growing prevalence of infectious diseases is expected to propel the growth of the polymerase chain reactions (PCR) devices, reagents and uses market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The rate of infectious disease incidence is rising due to increased travel, which facilitates the rapid spread of pathogens across borders. Polymerase chain reaction (PCR) devices, reagents, and uses aid in infectious disease diagnosis by enabling rapid and accurate detection of pathogens. They improve laboratory efficiency by amplifying genetic material, allowing timely identification and effective management of infections. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the growing prevalence of infectious diseases is driving the growth of the polymerase chain reactions (PCR) devices, reagents and uses industry.

Key Players In The Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market

Major companies operating in the polymerase chain reactions (pcr) devices, reagents and uses market are Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.

Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Trends and Insights

Major companies operating in the polymerase chain reactions (PCR) devices, reagents, and uses market are focused on developing advanced products such as advanced diagnostic tools to improve the accuracy and speed of genetic testing, facilitate early disease detection, and enhance research capabilities across various fields, including healthcare, environmental monitoring, and food safety. Advanced diagnostic tools are sophisticated medical instruments and technologies that enhance the accuracy, speed, and efficiency of diagnosing health conditions, enabling healthcare professionals to make informed decisions for patient care. For instance, in August 2023, Gold Standard Diagnostics, a Germany-based company that develops and manufactures diagnostic test kits, instruments, and reagents for a variety of industries, launched DNAllergen RT-PCR kits. DNAllergen RT-PCR kits are specialized molecular tools designed for the precise detection of specific allergens in food products, utilizing real-time polymerase chain reaction (PCR) technology. These kits provide enhanced sensitivity and specificity, allowing for the identification of allergens such as almond, celery, and fish, which can be challenging to detect with traditional methods.

What Are Latest Mergers And Acquisitions In The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

In June 2025, QIAGEN N.V., a Netherlands-based provider of molecular diagnostics solutions, partnered with Gencurix Inc. With this partnership, QIAGEN aims to develop multiplex oncology assays for tissue and liquid biopsies to broaden adoption of the QIAcuityDx digital PCR platform in clinical diagnostic laboratories. Gencurix Inc. is a South Korea-based molecular diagnostics company specializing in digital PCR assays and in vitro diagnostics.

Regional Outlook

North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2025. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

The polymerase chain reactions (PCR) devices and reagents market consists of sales of conventional PCR machines, qPCR, reverse transcription PCR, nested PCR, hot start PCR, and digital PCR devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.